Patents Assigned to IMMUNITOR, INC.
  • Publication number: 20200023046
    Abstract: A composition includes a metal chemically bound to at least one heat-denatured tumor antigen and at least one heat-denatured alloantigen. The tumor antigen and/or the alloantigen are hydrolyzed. The composition can be formulated in a tablet or pill. Methods of treatment of cancer and inflammatory diseases are also provided by administering, e.g., orally, the composition to a subject in need thereof.
    Type: Application
    Filed: April 9, 2019
    Publication date: January 23, 2020
    Applicant: IMMUNITOR, INC.
    Inventors: Aldar BOURINBAIAR, Vichai JIRATHITIKAL